FUJIFILM Presents Latest Innovative Medical Imaging at AHRA 2014

Stamford, C.T., August 11, 2014 (Booth # 710) – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, will highlight its growing digital radiography and women’s healthcare portfolio at the American Healthcare Radiology Administrators (AHRA) annual meeting held August 11 – 13 at the Gaylord National in Washington, DC.

Tomas Kuprys, MD from Loyola University Chicago will also provide an accredited presentation entitled “Orthopaedic Tomosynthesis as an Alternative Imaging Technology” at the AHRA 2014 annual meeting. The presentation will take place on Wednesday, August 13 from 7:15 AM – 8:15 AM sponsored by Fujifilm.

"Digital Tomosynthesis is an emerging technology that can provide a cost effective approach to screenings and produce sharp, clear images while reducing radiation dose,” said Tomas Kuprys, MD from Loyola University Chicago. “This session will enlighten the audience on the utilization of Digital Tomosynthesis in a variety of clinical applications, including Orthopedics and how it could benefit your department."

Attendees will receive 1 AART Category A CE Credit and learn to:

·         Understand how Digital Tomosynthesis can fit into your Radiology Department.

·         Recognize the value of alternative imaging in today’s Healthcare environment.

·         Appreciate the financial and dose benefit of Digital Tomosynthesis as an alternative to other modalities in your department.

Fujifilm continuously delivers legendary image quality, responsive support and renowned reliability with its digital radiography and women’s healthcare solutions. Following is a summary of offerings:

A Family of Digital Detectors
Radiology professionals and healthcare administrators interested in advanced visualization and analysis will find the innovations of DR flat panel detectors appealing for their diagnostic needs. Fujifilm's FDR D-EVO DR detectors are available in Gadolinium and Cesium models and and a full range of sizes including: 24x30cm Csl, 14x17 and 17x17. The 24x30cm detector is the world’s first 24x30cm size wireless cesium detector. It’s designed to offer advanced imaging capabilities, high DQE and low dose x-ray exams. Its size is perfect for every neonatal isolette tray and small anatomy exam.

A Range of Portables
Fujifilm's variety of mobile x-ray systems facilitate exceptional care at the patient bedside, in the emergency department, operating rooms, ICU, NICU or wherever general x-ray is needed.
Fujifilm’s FDR Go offers the speed, image quality and dose benefits of Fujifilm’s FDR D-EVO detectors and refined image processing, with enhanced portable features including a compact size that’s just right for maneuvering in tight spaces.
 
Most Advanced Digital Mammography Systems
Fujifilm is constantly innovating to develop the most advanced digital mammography systems, to assist in the early detection of breast cancer. Aspire Cristalle brings together Fujifilm’s extensive research, expertise and experience.  The Aspire Cristalle brings an innovative solution to breast imaging customers around the world. New advancements include:
• Patient Experience enhancements such as our patented Comfort Paddles, are designed to make the most uncomfortable part of mammograms, more comfortable. The paddle’s unique soft edges, flexible composition and 4-way pivot contours to the individual shape of the breast to more comfortably apply just the right compression for optimal tissue separation.
• Hexagonal Close Pattern (HCP) is an innovative detector pixel design, engineered to deliver higher acquisition efficiency and better signal to noise ratio, for finer detail, higher DQE, higher MTF and lower dose than conventional square pixel arrays.
The system’s image quality is further enhanced with Fujifilm’s renowned image processing, iAEC (intelligent automated exposure control) coupled with ISC (image based spectrum analysis), together these analyze the breast for glandular tissue characteristics and detect implants to optimize dose and processing, and precisely tune contrast, to intelligently adapt for every breast type and to image implants with ease.

For more information about Fujifilm, please visit: www.fujimed.com.

About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.

FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies.  In the year ended March 31, 2014, the company had global revenues of $23.7 billion, at an exchange rate of 103 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.